Hybrid Immunity and SARS-CoV-2 Antibodies: Results of the HEROES-RECOVER Prospective Cohort Study.

James K RomineHuashi LiMelissa M Coughlin Jefferson M Jones Amadea Britton Harmony L TynerSammantha B FullerRobin BloodworthLaura J EdwardsJini N EtolueTyler C MorrillGabriella Newes-AdeyiLauren E W OlshoManjusha GaglaniAshley FowlkesJames HollisterEdward J BedrickJennifer L UhrlaubShawn BeitelRyan S SprisslerZoe LyskiCynthia J PorterPatrick RiversKaren LutrickAlberto J Caban-MartinezSarang K YoonAndrew L PhillipsAllison L NalewayJefferey L BurgessKatherine D Ellingson

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)

Evidence of heterogeneity in antibody levels by permutations of infection and vaccination history could inform COVID-19 vaccination policy.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
public health
healthcare
single cell
mental health